02/05/2014
no comments
0
0
US drugs giant Pfizer has raised the price it is offering for the UK’s AstraZeneca to £50 a share, valuing the firm at £63bn.
BBC News – Business
You May Also Be Interested In:
- UK chip giant Arm files for blockbuster US share listing by Craig Taylor
- Wegovy: Weight-loss drug firm becomes Europe's most valuable by Craig Taylor
- Man Dies Due to Covid Jab! by Scotty ✅
- Silicon Valley Bank: Trading halted for firm behind global… by Craig Taylor
- Interest rates: No cut until 'solid evidence' price rises… by Craig Taylor
- US car giant agrees pay deal to end strike by Craig Taylor
0
0
